Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2018

Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Idiopathic Pulmonary Fibrosis (Respiratory), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.